Leave us your contacts and we’ll get back to you as soon as possible in order to organize a Zoom meeting to showcase the Triumf platform and discuss your questions.
In our previous blog posts, we have emphasised the importance of validating and evaluating digital health technologies (DHT) to ensure their safety and effectiveness. But what do we mean by “evidence-based” and what standards as well as regulations exist in the health care industry that help demonstrate the value but also increase the adoption of DHT? And what do we in Triumf do to ensure our health app for children is the highest quality possible?
Being a startup founder means I sometimes need to travel a lot and this blog post highlights some of the exciting events I have participated in over the past two months. Have a look!
We have recently added more paths to our Triumf health game, which is now available for following pediatric conditions: cancer, diabetes, asthma, overweight and surgery. After many months of hard work in improving the app to include more diseases, give better support and a more engaging experience, we finally also updated our visuals of the UI with a cute and toonish style that is better suited for our young audience. This blog post gives a visual overview of this major update.
This year has gone incredibly fast and the first half of the year is already over. So, this is a good point to reflect on what has happened so far for Triumf, the progress we have made but also to project forward and see what the next six months will bring us.
Our health app is available for several conditions, including cancer, diabetes, asthma, weight problems and children undergoing surgery. Last year, we had a valuable chance to involve childhood cancer patients in the design of Triumf game. We were able to demonstrate promising results amongst these patients. This time, our goal was to understand how our solution was perceived by diabetic patients, too. As such, in May we met with four charming testers from Estonian Society for Pediatric and Adolescent Diabetes (ELDÜ). The youngest partner was 9 years old, the oldest 12 years and their time from diagnosis varied from 3 to 10 years. The aim of the meeting was to have a joint testing session (although some also had a chance to test at home) to explore around in the game and give feedback on the experience.